Ezetimibe and Atelectasis - a phase IV clinical study of FDA data

Summary:

Atelectasis is reported as a side effect among people who take Ezetimibe (ezetimibe), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Asthma.

The phase IV clinical study analyzes which people have Atelectasis when taking Ezetimibe. It is created by eHealthMe based on reports of 30,221 people who have side effects when taking Ezetimibe from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,816 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Atelectasis?

Atelectasis (partial or complete collapse of the lung) is found to be associated with 1,518 drugs and 1,610 conditions by eHealthMe. Check the latest studies of Atelectasis.

On Oct, 01, 2025

30,221 people reported to have side effects when taking Ezetimibe.
Among them, 46 people (0.15%) have Atelectasis.

Among these 46 people:

How long have people been on Ezetimibe when they have Atelectasis? *

What is the gender of people who have Atelectasis when taking Ezetimibe? *

female: 7.32 %
male: 92.68 %

What is the age of people who have Atelectasis when taking Ezetimibe? *

What are other drugs people take besides Ezetimibe? *

What are other side effects people have besides Atelectasis? *

Cough: 30 people, 65.22%
Dyspnea (difficult or laboured breathing): 27 people, 58.70%
Restrictive Pulmonary Disease (reduction in total lung capacity): 23 people, 50.00%
Asthma: 23 people, 50.00%
Inspiratory Capacity Abnormal: 23 people, 50.00%
Hoarseness Or Changing Voice: 23 people, 50.00%
Full Blood Count Abnormal: 23 people, 50.00%
Eosinophil Count Increased: 23 people, 50.00%
Productive Cough: 23 people, 50.00%
Interstitial Lung Disease: 23 people, 50.00%

What are the existing conditions these people have? *

Asthma: 19 people, 41.30%
Multiple Myeloma (cancer of the plasma cells): 3 people, 6.52%
Depression: 3 people, 6.52%
High Blood Pressure: 3 people, 6.52%
Stable Angina (a constant chest pain): 2 people, 4.35%
Aortic Valve Incompetence: 2 people, 4.35%
Breast Cancer Metastatic: 2 people, 4.35%
Dyslipidaemia (abnormal amount of lipids): 2 people, 4.35%
Insomnia (sleeplessness): 2 people, 4.35%
Haemorrhage (bleeding): 2 people, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and have Atelectasis?

- Check whether Atelectasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ezetimibe:

Ezetimibe (30,816 reports)

Atelectasis treatments and more:

Atelectasis (17,087 reports)

How severe was Atelectasis and when was it recovered:

Atelectasis in Ezetimibe

Browse all side effects of Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atelectasis:

Atelectasis (1,518 drugs)

Browse all the conditions that are associated with Atelectasis:

Atelectasis (1,610 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe (the active ingredients of Ezetimibe) and Ezetimibe (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.